TMO

Thermo Fisher Scientific
D

TMO

Arincen67/100B

Thermo Fisher Scientific stock buybacks 1989–2026

Thermo Fisher Scientific spent 0.00 USD buying back its shares in Q3 FY2026, the three months to 26 September 2026, down 100.0% on the same quarter a year before. Thermo Fisher Scientific spent 3.00B USD buying back its shares in fiscal year 2025, down 25.0% on the year before.

Last updated 3 Nov 2026 · Next report 4 Feb 2027

Stock buybacks

Growth

Fiscal yearPeriod endingStock buybacksGrowthDividends paidFree cash flow
TTM26 Sept 2026——673.00M7.60B
FY202531 Dec 20253.00B-25.00%636.00M6.29B
FY202431 Dec 20244.00B+33.33%583.00M7.27B
FY202331 Dec 20233.00B0.00%523.00M6.93B
FY202231 Dec 20223.00B+50.00%455.00M6.91B
FY202131 Dec 20212.00B+33.33%395.00M7.02B
FY202031 Dec 20201.50B0.00%337.00M6.82B
FY201931 Dec 20191.50B+200.00%297.00M4.05B
FY201831 Dec 2018500.00M-33.33%266.00M3.79B
FY201731 Dec 2017750.00M-40.00%237.00M3.50B
FY201631 Dec 20161.25B+150.00%238.40M2.71B
FY201531 Dec 2015500.00M—240.60M2.39B
FY201431 Dec 20140.00-100.00%234.80M2.19B
FY201331 Dec 201389.80M-92.19%216.20M1.73B
FY201231 Dec 20121.15B-14.02%142.20M1.72B
FY201131 Dec 20111.34B+32.10%0.001.42B
FY201031 Dec 20101.01B+144.21%0.001.23B
FY200931 Dec 2009414.60M+121.24%0.001.45B
FY200831 Dec 2008187.40M-79.13%0.001.16B
FY200731 Dec 2007898.00M+199.33%0.001.31B
FY200631 Dec 2006300.00M—0.00328.86M
FY200531 Dec 20050.00—0.00227.37M
FY200431 Dec 20040.00-100.00%0.00214.53M
FY200331 Dec 200388.87M-73.40%0.00170.58M
FY200231 Dec 2002334.15M-34.66%0.0051.68M
FY200131 Dec 2001511.39M—0.00103.60M
FY200031 Dec 20000.00-100.00%0.00125.88M
FY199931 Dec 1999190.40M-59.54%0.00-150.88M
FY199831 Dec 1998470.60M+287.01%0.00-72.70M
FY199731 Dec 1997121.60M-13.70%0.00-691.70M
FY199631 Dec 1996140.90M+44.07%0.00100.00M
FY199531 Dec 199597.80M-3.65%0.00131.70M
FY199431 Dec 1994101.50M+77.45%0.00144.00M
FY199331 Dec 199357.20M+26.27%0.0070.10M
FY199231 Dec 199245.30M+287.18%0.00-5.10M
FY199131 Dec 199111.70M-55.85%0.00-10.50M
FY199031 Dec 199026.50M+227.16%600.00K-101.40M
FY198931 Dec 19898.10M—0.00-300.00K

Figures in USD. Free cash flow is operating cash flow less capital expenditure. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

The money spent buying back the company's own shares in each period, from the cash flow statement.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Cash flow

Common questions about Thermo Fisher Scientific's buybacks

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.